RGene Therapeutics Inc. preclinical data

The Woodlands, Texas, company reported that RGG-0853 significantly increased survival in mice bearing implants of human ovarian cancer.

At the Keystone Symposium on Gene Therapy in Steamboat, Colo., the company said 70 percent of treated mice survived a year, while implanted mice not given the treatment died within 160 days. ...